Cargando…

Intravenous Immunoglobulin Therapy for Critically Ill COVID-19 Patients With Different Inflammatory Phenotypes: A Multicenter, Retrospective Study

BACKGROUND: The benefits of intravenous immunoglobulin administration are controversial for critically ill COVID-19 patients. METHODS: We analyzed retrospectively the effects of immunoglobulin administration for critically ill COVID-19 patients. The primary outcome was 28-day mortality. Inverse prob...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yan, Xie, Jianfeng, Wu, Wenjuan, Li, Shusheng, Hu, Yu, Hu, Ming, Li, Jinxiu, Yang, Yi, Huang, Tingrong, Zheng, Kun, Wang, Yishan, Kang, Hanyujie, Huang, Yingzi, Jiang, Li, Zhang, Wei, Zhong, Ming, Sang, Ling, Zheng, Xia, Pan, Chun, Zheng, Ruiqiang, Li, Xuyan, Tong, Zhaohui, Qiu, Haibo, Weng, Li, Du, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828477/ https://www.ncbi.nlm.nih.gov/pubmed/35154067 http://dx.doi.org/10.3389/fimmu.2021.738532

Ejemplares similares

Clinical characteristics and outcomes of critically ill patients with novel coronavirus infectious disease (COVID-19) in China: a retrospective multicenter study
por: Xie, Jianfeng, et al.
Publicado: (2020)

Delayed Initiation of ECMO Is Associated With Poor Outcomes in Patients With Severe COVID-19: A Multicenter Retrospective Cohort Study
por: Li, Xuyan, et al.
Publicado: (2021)

A simple nomogram for predicting failure of non-invasive respiratory strategies in adults with COVID-19: a retrospective multicentre study
por: Liu, Ling, et al.
Publicado: (2021)

The effect of thymosin α1 on mortality of critical COVID-19 patients: A multicenter retrospective study
por: Sun, Qin, et al.
Publicado: (2021)

Clinical efficacy of intravenous immunoglobulin therapy in critical ill patients with COVID‐19: a multicenter retrospective cohort study
por: Shao, Ziyun, et al.
Publicado: (2020)

Effect of convalescent blood products for patients with severe acute respiratory infections of viral etiology: A systematic review and meta-analysis
por: Shao, Shuai, et al.
Publicado: (2021)

Application of high-flow nasal cannula in hypoxemic patients with COVID-19: a retrospective cohort study
por: Hu, Ming, et al.
Publicado: (2020)

High-dose of intravenous immunoglobulin modulates immune tolerance in premature infants
por: Liu, Pin, et al.
Publicado: (2018)

Predictors for Intravenous Immunoglobulin Resistance in Patients with Kawasaki Disease
por: Li, Wei, et al.
Publicado: (2022)

Neutrophil-to-lymphocyte ratio as a biomarker for predicting the intravenous immunoglobulin-resistant Kawasaki disease
por: Wu, Gang, et al.
Publicado: (2020)

High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China
por: Cao, Wei, et al.
Publicado: (2021)

Effectiveness of intravenous immunoglobulin alone and intravenous immunoglobulin combined with high-dose aspirin in the acute stage of Kawasaki disease: study protocol for a randomized controlled trial
por: Kuo, Ho-Chang, et al.
Publicado: (2018)

Efficacy of Intravenous Immunoglobulin/Exchange Transfusion Therapy on Gestational Alloimmune Liver Disease
por: Yeh, Pai-Jui, et al.
Publicado: (2021)

Risk-prediction models for intravenous immunoglobulin resistance in Kawasaki disease: Risk-of-Bias Assessment using PROBAST
por: Wang, Shuhui, et al.
Publicado: (2023)

Predictive model based on gene and laboratory data for intravenous immunoglobulin resistance in Kawasaki disease in a Chinese population
por: Meng, Li, et al.
Publicado: (2021)

Corrigendum: High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China
por: Cao, Wei, et al.
Publicado: (2021)

Cephalosporin-Induced Toxic Epidermal Necrolysis Treated with Intravenous Immunoglobulin
por: Boroda, Konstantin, et al.
Publicado: (2015)

INTRAVENOUS IMMUNOGLOBULIN IN DERMATOLOGY
por: Dhar, Sandipan
Publicado: (2009)

Is there an association between intravenous immunoglobulin resistance and coronary artery lesion in Kawasaki disease?—Current evidence based on a meta-analysis
por: Zheng, Xiaolan, et al.
Publicado: (2021)

Early neuromuscular blocking agents for adults with acute respiratory distress syndrome: a systematic review, meta-analysis and meta-regression
por: Shao, Shuai, et al.
Publicado: (2020)

Recruitment manoeuvres for adults with acute respiratory distress syndrome receiving mechanical ventilation: a systematic review and meta-analysis
por: Kang, Hanyujie, et al.
Publicado: (2019)

A novel model for predicting intravenous immunoglobulin-resistance in Kawasaki disease: a large cohort study
por: Wang, Shuhui, et al.
Publicado: (2023)

The therapeutic window of intravenous immunoglobulin (IVIG) and its correlation with clinical outcomes in Kawasaki disease: a systematic review and meta-analysis
por: Li, Zheng, et al.
Publicado: (2023)

Intravenous immunoglobulin for postpolio syndrome: a systematic review and meta-analysis
por: Huang, Yao-Hsien, et al.
Publicado: (2015)

Infliximab Treatment for Intravenous Immunoglobulin-resistant Kawasaki Disease: a Multicenter Study in Korea
por: Hur, Gyu, et al.
Publicado: (2018)

Sonographic Gallbladder Abnormality Is Associated with Intravenous Immunoglobulin Resistance in Kawasaki Disease
por: Chen, Chih-Jen, et al.
Publicado: (2012)

Binding Performance of Human Intravenous Immunoglobulin and 20(S)-7-Ethylcamptothecin
por: Liu, Yong-Chun, et al.
Publicado: (2018)

Site-specific N-glycosylation characterization of micro monoclonal immunoglobulins based on EThcD-sceHCD-MS/MS
por: Luo, Mengqi, et al.
Publicado: (2022)

Increased Ileal Immunoglobulin A Production and Immunoglobulin A-Coated Bacteria in Diarrhea-Predominant Irritable Bowel Syndrome
por: Liu, Yi, et al.
Publicado: (2020)

Corticosteroids and Intravenous Immunoglobulin in Pediatric Myocarditis: A Meta-Analysis
por: Li, Yining, et al.
Publicado: (2019)

Association of Serum Immunoglobulins Levels With Specific Disease Phenotypes of Crohn's Disease: A Multicenter Analysis in China
por: Song, Dong Juan, et al.
Publicado: (2021)

Immunoglobulin profiling identifies unique signatures in patients with Kawasaki disease during intravenous immunoglobulin treatment
por: Ko, Tai-Ming, et al.
Publicado: (2018)

Spontaneous Production of Immunoglobulin M in Human Epithelial Cancer Cells
por: Hu, Fanlei, et al.
Publicado: (2012)

Simplified acute physiology score III is excellent for predicting in-hospital mortality in coronary care unit patients with acute myocardial infarction: A retrospective study
por: Zheng, Xiaoyu, et al.
Publicado: (2022)

Nomogram to predict risk of resistance to intravenous immunoglobulin in children hospitalized with Kawasaki disease in Eastern China
por: Huang, Hongbiao, et al.
Publicado: (2022)

Clinical predictive risk factors prolonged the duration of SARS-CoV-2 clearance in 279 moderate COVID-19 patients: A multicenter retrospective cohort study
por: Wu, Xinxin, et al.
Publicado: (2021)

Intravenous Immunoglobulin to Suppress Progression in a Patient With Advanced Breast Cancer
por: Lin, Kai-Liang, et al.
Publicado: (2022)

Plasma Clusterin Concentrations May Predict Resistance to Intravenous Immunoglobulin in Patients with Kawasaki Disease
por: Ou-Yang, Mei-Chen, et al.
Publicado: (2013)

Convalescent Plasma for Coronavirus Disease 2019: Dose is the Key
por: Yu, Jiangquan, et al.
Publicado: (2021)

Effectiveness and Tolerability of Micafungin in Chinese Patients with Invasive Fungal Infections: A Retrospective, Multicenter Study
por: Zheng, Xiaoyun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_k581munaipr1t8sc9hidqtcg4e